Peer-influenced content. Sources you trust. No registration required. This is HCN.
Medical News Today (MNT)
Loss of PRDM16 in adipocytes leads to increased sensitivity to ANGII and vascular fibrosis resulting in elevated blood pressure.
Cardiology January 26th 2026
Conexiant
LDL-C reductions were evident by week 4 and sustained through 52 weeks (−55.3% vs 8.7%).
Cardiology January 6th 2026
Annals of Internal Medicine
“For persons at low cardiovascular risk, reducing or modifying saturated fat intake has little or no benefit over a period of 5 years.”
Cleveland Clinic Journal of Medicine (CCJM)
“Pelacarsen lowered lipoprotein(a) to less than 50 mg/dL in 98% of participants, but levels rebounded after 16 weeks.”
Cardiology December 3rd 2025
MDLinx
“The main scenario that prompts me to use apoB is when a patient’s traditional lipid panel values are either normal, or even slightly abnormal, but have discrepancy with the quality/quantity of their other comorbid problems.” — Austin Shuxiao, MD
Cardiology September 16th 2025
Triple therapy was linked with slower decline of overall cognition, particularly in semantic and working memory, and showed lower odds of atherosclerosis, reduced AD pathology, and fewer protein buildups.
Cardiology August 20th 2025
DIET & NUTRITION 
PATIENT EDUCATION 
OBESITY/WEIGHT MANAGEMENT 
EXERCISE/TRAINING 
LEGAL MATTERS 
GUIDELINES/RECOMMENDATIONS